X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs FRESENIUS KABI ONCO. - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD FRESENIUS KABI ONCO. MERCK LTD/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 33.7 22.1 152.3% View Chart
P/BV x 3.8 3.1 121.2% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 MERCK LTD   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    MERCK LTD
Dec-16
FRESENIUS KABI ONCO.
Mar-13
MERCK LTD/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,060176 602.3%   
Low Rs62379 793.6%   
Sales per share (Unadj.) Rs632.437.7 1,678.2%  
Earnings per share (Unadj.) Rs45.75.1 897.6%  
Cash flow per share (Unadj.) Rs62.36.7 926.8%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.842.5 913.9%  
Shares outstanding (eoy) m16.60158.23 10.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.4 39.4%   
Avg P/E ratio x18.425.0 73.7%  
P/CF ratio (eoy) x13.518.9 71.3%  
Price / Book Value ratio x2.23.0 72.4%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,96920,135 69.4%   
No. of employees `0001.61.2 137.4%   
Total wages/salary Rs m1,487703 211.4%   
Avg. sales/employee Rs Th6,631.95,176.2 128.1%   
Avg. wages/employee Rs Th939.2610.4 153.9%   
Avg. net profit/employee Rs Th479.4699.6 68.5%   
INCOME DATA
Net Sales Rs m10,4985,963 176.1%  
Other income Rs m24218 1,346.7%   
Total revenues Rs m10,7415,981 179.6%   
Gross profit Rs m1,1351,430 79.4%  
Depreciation Rs m276258 106.8%   
Interest Rs m0-26 0.0%   
Profit before tax Rs m1,1021,216 90.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m343342 100.3%   
Profit after tax Rs m759806 94.2%  
Gross profit margin %10.824.0 45.1%  
Effective tax rate %31.128.1 110.7%   
Net profit margin %7.213.5 53.5%  
BALANCE SHEET DATA
Current assets Rs m6,4105,102 125.6%   
Current liabilities Rs m8,8282,385 370.1%   
Net working cap to sales %-23.045.6 -50.6%  
Current ratio x0.72.1 33.9%  
Inventory Days Days58150 38.4%  
Debtors Days Days38113 33.9%  
Net fixed assets Rs m1,4065,148 27.3%   
Share capital Rs m166158 104.9%   
"Free" reserves Rs m6,2866,556 95.9%   
Net worth Rs m6,4556,732 95.9%   
Long term debt Rs m0952 0.0%   
Total assets Rs m8,82810,388 85.0%  
Interest coverage xNM-45.8-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.6 207.2%   
Return on assets %8.67.5 114.5%  
Return on equity %11.812.0 98.2%  
Return on capital %17.114.6 116.9%  
Exports to sales %8.374.5 11.1%   
Imports to sales %21.024.8 84.9%   
Exports (fob) Rs m8694,441 19.6%   
Imports (cif) Rs m2,2091,477 149.5%   
Fx inflow Rs m9595,298 18.1%   
Fx outflow Rs m2,6121,772 147.4%   
Net fx Rs m-1,6533,525 -46.9%   
CASH FLOW
From Operations Rs m1,0701,274 84.0%  
From Investments Rs m-750-1,204 62.3%  
From Financial Activity Rs m-150-196 76.4%  
Net Cashflow Rs m171-126 -135.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 81.0 64.0%  
Indian inst/Mut Fund % 18.2 0.3 6,066.7%  
FIIs % 1.0 9.6 10.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 9.1 319.8%  
Shareholders   28,591 42,599 67.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 19, 2018 12:07 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ABBOTT INDIA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS